Merck & Co.
Search results
For 175 years, Pfizer has been a trusted partner in healthcare – discovering, developing, and delivering medical breakthroughs to prevent, treat, and cure some of the world’s most vexing conditions and diseases. Learn more about our history.
Homepage | Pfizer Singapore. Science Contact Us. Breakthroughs that Change Patients' Lives Pfizer Colleagues Work to Challenge the Mos t Feared Diseases of Our Time Learn More Coronavirus Resources Current information on our scientific progress Learn More Innovative Therapies for Tomorrow Translating advanced science and technologies into ...
Pfizer Inc. ( / ˈfaɪzər / FY-zər) [3] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
At Pfizer, we’re driven to discover the cure - driven to significantly improve the lives of everyone, everywhere. If you’re similarly driven, you’ll find there’s no better place to begin (and continue) your career than at Pfizer.
We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our portfolio of medicines for therapeutic areas include vaccines, oncology, cardiovascular diseases, infectious diseases, immunological disorders, rare diseases and mental health.
6 days ago · SINGAPORE - US pharmaceutical giant Pfizer opened its new $1 billion plant in Singapore on July 23. The 429,000 sq ft plant in Tuas Biomedical Park will produce active pharmaceutical ingredients ...
Dec 11, 2020 · COMIRNATY is the first COVID-19 vaccine to be granted FDA approval. Approval is based on a comprehensive submission package including six-month efficacy and safety data after second dose. More than 1.2 billion Pfizer-BioNTech doses have been delivered to more than 120 countries or territories around the world since December 2020.
Pfizer Inc. and BioNTech SE today announced positive topline results from a Phase 1/2 study (NCT05596734) evaluating the safety, tolerability and immunogenicity of mRNA-based combination vaccine candidates for influenza and COVID-19 among healthy adults 18 to 64 years of age. 10.13.2023
Jul 23, 2024 · PHOTO: PFIZER. US DRUGMAKER Pfizer on Tuesday (Jul 23) opened a S$1 billion extension in Tuas to produce active pharmaceutical ingredients (APIs) for its oncology, pain and antibiotic medicines. Over 250 skilled jobs are set to be created by 2026 at the Tuas II facility that spans 429,000 square feet. So far, 230 roles have already been filled ...
Dec 12, 2022 · From 12 December 2022, the Ministry of Health (MOH) will roll out the bivalent Pfizer-BioNTech/Comirnaty COVID-19 vaccine at all current Pfizer-BioNTech/ Comirnaty vaccination locations for persons aged 12 years and above.
